Pinpoint Science

Pinpoint Science

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Pinpoint Science is an early-stage private diagnostics company leveraging a proprietary silicon chip nanopore sensor. The platform promises scalability alongside high analytical performance, positioning it for potential applications in sensitive detection markets. However, the company appears to be in a very early operational phase, as evidenced by its minimal web presence and placeholder website content. Key details regarding leadership, pipeline, and funding remain undisclosed to the public.

Diagnostics

Technology Platform

Silicon chip nanopore sensor platform for scalable, high-sensitivity, high-specificity molecular detection.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing demand for decentralized, low-cost, and highly accurate molecular diagnostics presents a significant market opportunity.
A successfully scaled silicon chip nanopore platform could enable rapid, multiplexed testing at the point-of-care for infectious diseases, oncology, and other conditions.

Risk Factors

Substantial technical risk in developing a robust and manufacturable nanopore sensor.
High competitive and financial risks, with no visible pipeline, partnerships, or funding details, and a prolonged development timeline since founding in 2015.

Competitive Landscape

The nanopore-based diagnostics field is competitive, dominated by players like Oxford Nanopore Technologies and numerous startups. Success requires achieving superior performance, cost, or ease-of-use, and securing strong intellectual property in a crowded space.